| The North American Neuroendocrine Tumor Society consensus paper on the surgical management of pancreatic neuroendocrine tumors JR Howe, NB Merchant, C Conrad, XM Keutgen, J Hallet, JA Drebin, ... Pancreas 49 (1), 1-33, 2020 | 341 | 2020 |
| Prophylactic central neck dissection and local recurrence in papillary thyroid cancer: a meta-analysis T Zetoune, X Keutgen, D Buitrago, H Aldailami, H Shao, M Mazumdar, ... Annals of surgical oncology 17, 3287-3293, 2010 | 237 | 2010 |
| A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration XM Keutgen, F Filicori, MJ Crowley, Y Wang, T Scognamiglio, R Hoda, ... Clinical Cancer Research 18 (7), 2032-2038, 2012 | 195 | 2012 |
| The role of chelators in preventing biofilm formation and catheter-related bloodstream infections II Raad, X Fang, XM Keutgen, Y Jiang, R Sherertz, R Hachem Current opinion in infectious diseases 21 (4), 385-392, 2008 | 153 | 2008 |
| The Chicago consensus on peritoneal surface malignancies: management of appendiceal neoplasms Annals of surgical oncology 27 (6), 1753-1760, 2020 | 146* | 2020 |
| Management of anaplastic thyroid cancer XM Keutgen, SM Sadowski, E Kebebew Gland surgery 4 (1), 44, 2015 | 134 | 2015 |
| Resection of primary tumor site is associated with prolonged survival in metastatic nonfunctioning pancreatic neuroendocrine tumors XM Keutgen, N Nilubol, J Glanville, SM Sadowski, DJ Liewehr, ... Surgery 159 (1), 311-319, 2016 | 119 | 2016 |
| A general method to derive robust organ-specific gene expression-based differentiation indices: application to thyroid cancer diagnostic G Tomás, M Tarabichi, D Gacquer, A Hebrant, G Dom, JE Dumont, ... Oncogene 31 (41), 4490-4498, 2012 | 116 | 2012 |
| Resection of primary tumor may prolong survival in metastatic gastroenteropancreatic neuroendocrine tumors JF Tierney, SV Chivukula, X Wang, SG Pappas, E Schadde, M Hertl, ... Surgery 165 (3), 644-651, 2019 | 111 | 2019 |
| Evaluation and management of pancreatic lesions in patients with von Hippel–Lindau disease XM Keutgen, P Hammel, PL Choyke, SK Libutti, E Jonasch, E Kebebew Nature reviews Clinical oncology 13 (9), 537-549, 2016 | 102 | 2016 |
| Prognostic utility of total 68Ga-DOTATATE-avid tumor volume in patients with neuroendocrine tumors A Tirosh, GZ Papadakis, C Millo, D Hammoud, SM Sadowski, ... Gastroenterology 154 (4), 998-1008. e1, 2018 | 80 | 2018 |
| Intercellular adhesion molecule-1 (ICAM-1) is upregulated in aggressive papillary thyroid carcinoma D Buitrago, XM Keutgen, M Crowley, F Filicori, H Aldailami, R Hoda, ... Annals of surgical oncology 19, 973-980, 2012 | 77 | 2012 |
| Predictive factors of morbidity and mortality in grade IV and V liver trauma undergoing perihepatic packing: single institution 14 years experience at European trauma centre S Di Saverio, F Catena, F Filicori, L Ansaloni, F Coccolini, XM Keutgen, ... Injury 43 (9), 1347-1354, 2012 | 76 | 2012 |
| The Chicago consensus on peritoneal surface malignancies: management of colorectal metastases Annals of surgical oncology 27 (6), 1761-1767, 2020 | 70 | 2020 |
| Malignant-functioning neuroendocrine tumors of the pancreas: A survival analysis XM Keutgen, N Nilubol, E Kebebew Surgery 159 (5), 1382-1389, 2016 | 69 | 2016 |
| Dicer expression and microRNA dysregulation associate with aggressive features in thyroid cancer P Erler, XM Keutgen, MJ Crowley, T Zetoune, A Kundel, D Kleiman, ... Surgery 156 (6), 1342-1350, 2014 | 62 | 2014 |
| The Chicago consensus on peritoneal surface malignancies: management of gastric metastases Annals of surgical oncology 27 (6), 1768-1773, 2020 | 59* | 2020 |
| Deep learning prediction of BRAF-RAS gene expression signature identifies noninvasive follicular thyroid neoplasms with papillary-like nuclear features JM Dolezal, A Trzcinska, CY Liao, S Kochanny, E Blair, N Agrawal, ... Modern Pathology 34 (5), 862-874, 2021 | 54 | 2021 |
| The Chicago Consensus on peritoneal surface malignancies: management of peritoneal mesothelioma Annals of surgical oncology 27 (6), 1774-1779, 2020 | 51 | 2020 |
| A tumor DNA complex aberration index is an independent predictor of survival in breast and ovarian cancer HKM Vollan, OM Rueda, SF Chin, C Curtis, G Turashvili, S Shah, ... Molecular oncology 9 (1), 115-127, 2015 | 51 | 2015 |